Please use this identifier to cite or link to this item: https://hdl.handle.net/1959.11/60737
Title: Global economic cost of smoking-attributable diseases
Contributor(s): Goodchild, Mark (author); Nargis, Nigar (author); Tursan d'espaignet, Edouard  (author)orcid 
Publication Date: 2018
Open Access: Yes
DOI: 10.1136/tobaccocontrol-2016-053305
Handle Link: https://hdl.handle.net/1959.11/60737
Abstract: 

Background The detrimental impact of smoking on health has been widely documented since the 1960s. Numerous studies have also quantified the economic cost that smoking imposes on society. However, these studies have mostly been in high income countries, with limited documentation from developing countries. The aim of this paper is to measure the economic cost of smoking-attributable diseases in countries throughout the world, including in low- and middle-income settings.

Methods The Cost of Illness approach is used to estimate the economic cost of smoking attributable-diseases in 2012. Under this approach, economic costs are defined as either 'direct costs' such as hospital fees or 'indirect costs' representing the productivity loss from morbidity and mortality. The same method was applied to 152 countries, which had all the necessary data, representing 97% of the world's smokers.

Findings The amount of healthcare expenditure due to smoking-attributable diseases totalled purchasing power parity (PPP) $467 billion (US$422 billion) in 2012, or 5.7% of global health expenditure. The total economic cost of smoking (from health expenditures and productivity losses together) totalled PPP $1852 billion (US$1436 billion) in 2012, equivalent in magnitude to 1.8% of the world's annual gross domestic product (GDP). Almost 40% of this cost occurred in developing countries, highlighting the substantial burden these countries suffer.

Conclusions Smoking imposes a heavy economic burden throughout the world, particularly in Europe and North America, where the tobacco epidemic is most advanced. These findings highlight the urgent need for countries to implement stronger tobacco control measures to address these costs.

Publication Type: Journal Article
Source of Publication: Tobacco Control, v.27, p. 58-64
Publisher: BMJ Group
Place of Publication: United Kingdom
ISSN: 1468-3318
0964-4563
Fields of Research (FoR) 2020: 3214 Pharmacology and pharmaceutical sciences
Peer Reviewed: Yes
HERDC Category Description: C1 Refereed Article in a Scholarly Journal
Appears in Collections:Journal Article
School of Rural Medicine

Files in This Item:
2 files
File Description SizeFormat 
openpublished/GlobalTursanespaignet2018JournalArticle.pdfPublished version416.74 kBAdobe PDF
Download Adobe
View/Open
Show full item record
Google Media

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons